IL-1β plays a key role in TMD pathophysiology by influencing pain and cartilage damage, while elevated synovial IL-6 and TNF-α levels in symptomatic patients underscore their involvement in local inflammation [22,32]. The gene discussed is IL6; the disease is temporomandibular joint disorder.